Eric Austin
Last active: 2/21/2017

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease. Gaskill C, Marriott S, Pratap S, Menon S, Hedges LK, Fessel JP, Kropski JA, Ames D, Wheeler L, Loyd JE, Hemnes AR, Roop DR, Klemm DJ, Austin ED, Majka SM (2016) Pulm Circ 6(4): 483-497
    › Primary publication · 28090290 (PubMed) · PMC5210051 (PubMed Central)
  2. Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers. Gu M, Shao NY, Sa S, Li D, Termglinchan V, Ameen M, Karakikes I, Sosa G, Grubert F, Lee J, Cao A, Taylor S, Ma Y, Zhao Z, Chappell J, Hamid R, Austin ED, Gold JD, Wu JC, Snyder MP, Rabinovitch M (2017) Cell Stem Cell 20(4): 490-504.e5
    › Primary publication · 28017794 (PubMed) · PMC5500296 (PubMed Central)
  3. Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry. Humpl T, Berger RMF, Austin ED, Fasnacht Boillat MS, Bonnet D, Ivy DD, Zuk M, Beghetti M, Schulze-Neick I (2017) Cardiol Young 27(6): 1123-1132
    › Primary publication · 27995825 (PubMed)
  4. Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia. Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, Truog WE, McGrath-Morrow SA, Moore PE, Rhein LM, Kirpalani H, Zhang H, Gratny LL, Lynch SK, Curtiss J, Stonestreet BS, McKinney RL, Dysart KC, Gien J, Baker CD, Donohue PK, Austin E, Fike C, Nelin LD, Bronchopulmonary Dysplasia Collaborative (2017) J Pediatr : 12-28.e1
    › Primary publication · 27908648 (PubMed) · PMC5562402 (PubMed Central)
  5. Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy. Han B, Copeland CA, Kawano Y, Rosenzweig EB, Austin ED, Shahmirzadi L, Tang S, Raghunathan K, Chung WK, Kenworthy AK (2016) Traffic 17(12): 1297-1312
    › Primary publication · 27717241 (PubMed) · PMC5197452 (PubMed Central)
  6. Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing. Austin ED, West J, Loyd JE, Hemnes AR (2017) Am J Respir Crit Care Med 195(1): 23-31
    › Primary publication · 27398627 (PubMed) · PMC5214922 (PubMed Central)
  7. Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension. Yang J, Nies MK, Fu Z, Damico R, Korley FK, Hassoun PM, Ivy DD, Austin ED, Everett AD (2016) Am J Respir Crit Care Med 194(10): 1264-1272
    › Primary publication · 27254543 (PubMed) · PMC5114441 (PubMed Central)
  8. Pulmonary hypertension in the premature infant: a challenging comorbidity in a vulnerable population. O'Connor MG, Cornfield DN, Austin ED (2016) Curr Opin Pediatr 28(3): 324-30
    › Primary publication · 27043088 (PubMed) · PMC4894759 (PubMed Central)
  9. Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension. Brittain EL, Talati M, Fessel JP, Zhu H, Penner N, Calcutt MW, West JD, Funke M, Lewis GD, Gerszten RE, Hamid R, Pugh ME, Austin ED, Newman JH, Hemnes AR (2016) Circulation 133(20): 1936-44
    › Primary publication · 27006481 (PubMed) · PMC4870107 (PubMed Central)
  10. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. Hemnes AR, Zhao M, West J, Newman JH, Rich S, Archer SL, Robbins IM, Blackwell TS, Cogan J, Loyd JE, Zhao Z, Gaskill C, Jetter C, Kropski JA, Majka SM, Austin ED (2016) Am J Respir Crit Care Med 194(4): 464-75
    › Primary publication · 26926454 (PubMed) · PMC5003329 (PubMed Central)
  11. Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction. Mar PL, Nwazue V, Black BK, Biaggioni I, Diedrich A, Paranjape SY, Loyd JE, Hemnes AR, Robbins IM, Robertson D, Raj SR, Austin ED (2016) Chest 149(5): 1252-60
    › Primary publication · 26836906 (PubMed) · PMC4944774 (PubMed Central)
  12. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Evans JD, Girerd B, Montani D, Wang XJ, Galiè N, Austin ED, Elliott G, Asano K, Grünig E, Yan Y, Jing ZC, Manes A, Palazzini M, Wheeler LA, Nakayama I, Satoh T, Eichstaedt C, Hinderhofer K, Wolf M, Rosenzweig EB, Chung WK, Soubrier F, Simonneau G, Sitbon O, Gräf S, Kaptoge S, Di Angelantonio E, Humbert M, Morrell NW (2016) Lancet Respir Med 4(2): 129-37
    › Primary publication · 26795434 (PubMed) · PMC4737700 (PubMed Central)
  13. Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. Kinsella JP, Steinhorn RH, Krishnan US, Feinstein JA, Adatia I, Austin ED, Rosenzweig EB, Everett AD, Fineman JR, Hanna BD, Hopper RK, Humpl T, Ivy DD, Keller RL, Mullen MP, Raj JU, Wessel DL, Abman SH (2016) J Pediatr : 312-4
    › Primary publication · 26703869 (PubMed)
  14. Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension. Yan L, Chen X, Talati M, Nunley BW, Gladson S, Blackwell T, Cogan J, Austin E, Wheeler F, Loyd J, West J, Hamid R (2016) Am J Respir Crit Care Med 193(8): 898-909
    › Primary publication · 26651104 (PubMed) · PMC4849178 (PubMed Central)
  15. Toward Precision Medicine in Pulmonary Arterial Hypertension. Austin ED, Loyd JE (2015) Am J Respir Crit Care Med 192(11): 1272-4
    › Primary publication · 26623685 (PubMed) · PMC4731706 (PubMed Central)
  16. Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation. Huang J, Wolk JH, Gewitz MH, Loyd JE, West J, Austin ED, Mathew R (2015) World J Cardiol 7(10): 671-84
    › Primary publication · 26516422 (PubMed) · PMC4620079 (PubMed Central)
  17. Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism. Chen X, Talati M, Fessel JP, Hemnes AR, Gladson S, French J, Shay S, Trammell A, Phillips JA, Hamid R, Cogan JD, Dawson EP, Womble KE, Hedges LK, Martinez EG, Wheeler LA, Loyd JE, Majka SJ, West J, Austin ED (2016) Circulation 133(1): 82-97
    › Primary publication · 26487756 (PubMed) · PMC4698046 (PubMed Central)
  18. Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects. Machado RD, Southgate L, Eichstaedt CA, Aldred MA, Austin ED, Best DH, Chung WK, Benjamin N, Elliott CG, Eyries M, Fischer C, Gräf S, Hinderhofer K, Humbert M, Keiles SB, Loyd JE, Morrell NW, Newman JH, Soubrier F, Trembath RC, Viales RR, Grünig E (2015) Hum Mutat 36(12): 1113-27
    › Primary publication · 26387786 (PubMed) · PMC4822159 (PubMed Central)
  19. Letter by Mosley Regarding Article, "Iron Homeostasis and Pulmonary Hypertension: Iron Deficiency Leads to Pulmonary Vascular Remodeling in the Rat". Mosley JD, Brittain EL, Loyd JE, Denny JC, Austin ED, Larkin EK (2015) Circ Res 117(6): e56-7
    › Primary publication · 26316607 (PubMed) · PMC4557206 (PubMed Central)
  20. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Damico R, Kolb TM, Valera L, Wang L, Housten T, Tedford RJ, Kass DA, Rafaels N, Gao L, Barnes KC, Benza RL, Rand JL, Hamid R, Loyd JE, Robbins IM, Hemnes AR, Chung WK, Austin ED, Drummond MB, Mathai SC, Hassoun PM (2015) Am J Respir Crit Care Med 191(2): 208-18
    › Primary publication · 25489667 (PubMed) · PMC4347439 (PubMed Central)
  21. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension. Prewitt AR, Ghose S, Frump AL, Datta A, Austin ED, Kenworthy AK, de Caestecker MP (2015) J Biol Chem 290(2): 960-71
    › Primary publication · 25411245 (PubMed) · PMC4294523 (PubMed Central)
  22. Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension. Hemnes AR, Trammell AW, Archer SL, Rich S, Yu C, Nian H, Penner N, Funke M, Wheeler L, Robbins IM, Austin ED, Newman JH, West J (2015) Circulation 131(4): 401-9; discussion 409
    › Primary publication · 25361553 (PubMed) · PMC4308423 (PubMed Central)
  23. Repair of anomalous aortic origin of a coronary artery in 113 patients: a Congenital Heart Surgeons' Society report. Poynter JA, Bondarenko I, Austin EH, DeCampli WM, Jacobs JP, Ziemer G, Kirshbom PM, Tchervenkov CI, Karamlou T, Blackstone EH, Walters HL, Gaynor JW, Mery CM, Pearl JM, Brothers JA, Caldarone CA, Williams WG, Jacobs ML, Mavroudis C, Congenital Heart Surgeons’ Society AAOCA Working Group (2014) World J Pediatr Congenit Heart Surg 5(4): 507-14
    › Primary publication · 25324246 (PubMed)
  24. Genetics of pulmonary hypertension. Best DH, Austin ED, Chung WK, Elliott CG (2014) Curr Opin Cardiol 29(6): 520-7
    › Primary publication · 25159282 (PubMed)
  25. ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling. Marriott S, Baskir RS, Gaskill C, Menon S, Carrier EJ, Williams J, Talati M, Helm K, Alford CE, Kropski JA, Loyd J, Wheeler L, Johnson J, Austin E, Nozik-Grayck E, Meyrick B, West JD, Klemm DJ, Majka SM (2014) Am J Physiol Cell Physiol 307(8): C684-98
    › Primary publication · 25122876 (PubMed) · PMC4200000 (PubMed Central)
  26. Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension. Benson L, Brittain EL, Pugh ME, Austin ED, Fox K, Wheeler L, Robbins IM, Hemnes AR (2014) Pulm Circ 4(2): 311-8
    › Primary publication · 25006450 (PubMed) · PMC4070784 (PubMed Central)
  27. The genetics of pulmonary arterial hypertension. Austin ED, Loyd JE (2014) Circ Res 115(1): 189-202
    › Primary publication · 24951767 (PubMed) · PMC4137413 (PubMed Central)
  28. Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertension. Brittain EL, Janz DR, Austin ED, Bastarache JA, Wheeler LA, Ware LB, Hemnes AR (2014) Chest 146(6): 1478-1485
    › Primary publication · 24945582 (PubMed) · PMC4251612 (PubMed Central)
  29. Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension. West JD, Austin ED, Gaskill C, Marriott S, Baskir R, Bilousova G, Jean JC, Hemnes AR, Menon S, Bloodworth NC, Fessel JP, Kropski JA, Irwin D, Ware LB, Wheeler L, Hong CC, Meyrick B, Loyd JE, Bowman AB, Ess KC, Klemm DJ, Young PP, Merryman WD, Kotton D, Majka SM (2014) Am J Physiol Cell Physiol 307(5): C415-30
    › Primary publication · 24871858 (PubMed) · PMC4154073 (PubMed Central)
  30. Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension. West J, Austin E, Fessel JP, Loyd J, Hamid R (2014) Drug Discov Today 19(8): 1241-5
    › Primary publication · 24794464 (PubMed) · PMC4396626 (PubMed Central)
  31. Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Austin ED, Kawut SM, Gladwin MT, Abman SH (2014) Ann Am Thorac Soc : S178-85
    › Primary publication · 24754827 (PubMed) · PMC4112504 (PubMed Central)
  32. Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function. Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Larkin EK, Austin ED, Hemnes AR (2013) Pulm Circ 3(3): 589-98
    › Primary publication · 24618543 (PubMed) · PMC4070798 (PubMed Central)
  33. Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension. Fessel JP, Chen X, Frump A, Gladson S, Blackwell T, Kang C, Johnson J, Loyd JE, Hemnes A, Austin E, West J (2013) Pulm Circ 3(3): 564-77
    › Primary publication · 24618541 (PubMed) · PMC4070799 (PubMed Central)
  34. An evidence-based knowledgebase of pulmonary arterial hypertension to identify genes and pathways relevant to pathogenesis. Zhao M, Austin ED, Hemnes AR, Loyd JE, Zhao Z (2014) Mol Biosyst 10(4): 732-40
    › Primary publication · 24448676 (PubMed) · PMC3950334 (PubMed Central)
  35. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension. Hemnes AR, Brittain EL, Trammell AW, Fessel JP, Austin ED, Penner N, Maynard KB, Gleaves L, Talati M, Absi T, Disalvo T, West J (2014) Am J Respir Crit Care Med 189(3): 325-34
    › Primary publication · 24274756 (PubMed) · PMC3977729 (PubMed Central)
  36. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension. Frump AL, Lowery JW, Hamid R, Austin ED, de Caestecker M (2013) PLoS One 8(11): e80319
    › Primary publication · 24224048 (PubMed) · PMC3818254 (PubMed Central)
  37. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG (2014) Chest 145(2): 231-236
    › Primary publication · 24135949 (PubMed) · PMC3921094 (PubMed Central)
  38. Childhood interstitial lung diseases: an 18-year retrospective analysis. Soares JJ, Deutsch GH, Moore PE, Fazili MF, Austin ED, Brown RF, Sokolow AG, Hilmes MA, Young LR (2013) Pediatrics 132(4): 684-91
    › Primary publication · 24081995 (PubMed) · PMC3784299 (PubMed Central)
  39. Heritable forms of pulmonary arterial hypertension. Austin ED, Loyd JE (2013) Semin Respir Crit Care Med 34(5): 568-80
    › Primary publication · 24037626 (PubMed) · PMC4102304 (PubMed Central)
  40. Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension. Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Austin ED, Hemnes AR (2013) JACC Heart Fail 1(4): 300-307
    › Primary publication · 24015376 (PubMed) · PMC3763862 (PubMed Central)
  41. Gender, sex hormones and pulmonary hypertension. Austin ED, Lahm T, West J, Tofovic SP, Johansen AK, Maclean MR, Alzoubi A, Oka M (2013) Pulm Circ 3(2): 294-314
    › Primary publication · 24015330 (PubMed) · PMC3757824 (PubMed Central)
  42. A novel channelopathy in pulmonary arterial hypertension. Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouët DA, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS, Chung WK (2013) N Engl J Med 369(4): 351-361
    › Primary publication · 23883380 (PubMed) · PMC3792227 (PubMed Central)
  43. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Germain M, Eyries M, Montani D, Poirier O, Girerd B, Dorfmüller P, Coulet F, Nadaud S, Maugenre S, Guignabert C, Carpentier W, Vonk-Noordegraaf A, Lévy M, Chaouat A, Lambert JC, Bertrand M, Dupuy AM, Letenneur L, Lathrop M, Amouyel P, de Ravel TJ, Delcroix M, Austin ED, Robbins IM, Hemnes AR, Loyd JE, Berman-Rosenzweig E, Barst RJ, Chung WK, Simonneau G, Trégouët DA, Humbert M, Soubrier F (2013) Nat Genet 45(5): 518-21
    › Primary publication · 23502781 (PubMed) · PMC3983781 (PubMed Central)
  44. Outcomes of congenital diaphragmatic hernia in the modern era of management. Wynn J, Krishnan U, Aspelund G, Zhang Y, Duong J, Stolar CJ, Hahn E, Pietsch J, Chung D, Moore D, Austin E, Mychaliska G, Gajarski R, Foong YL, Michelfelder E, Potolka D, Bucher B, Warner B, Grady M, Azarow K, Fletcher SE, Kutty S, Delaney J, Crombleholme T, Rosenzweig E, Chung W, Arkovitz MS (2013) J Pediatr 163(1): 114-9.e1
    › Primary publication · 23375362 (PubMed) · PMC3692597 (PubMed Central)
  45. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. Larkin EK, Newman JH, Austin ED, Hemnes AR, Wheeler L, Robbins IM, West JD, Phillips JA, Hamid R, Loyd JE (2012) Am J Respir Crit Care Med 186(9): 892-6
    › Primary publication · 22923661 (PubMed) · PMC3530218 (PubMed Central)
  46. Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance. Cogan J, Austin E, Hedges L, Womack B, West J, Loyd J, Hamid R (2012) Circulation 126(15): 1907-16
    › Primary publication · 22923426 (PubMed) · PMC4113011 (PubMed Central)
  47. Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Austin ED, Ma L, LeDuc C, Berman Rosenzweig E, Borczuk A, Phillips JA, Palomero T, Sumazin P, Kim HR, Talati MH, West J, Loyd JE, Chung WK (2012) Circ Cardiovasc Genet 5(3): 336-43
    › Primary publication · 22474227 (PubMed) · PMC3380156 (PubMed Central)
  48. BMPR2 expression is suppressed by signaling through the estrogen receptor. Austin ED, Hamid R, Hemnes AR, Loyd JE, Blackwell T, Yu C, Phillips Iii JA, Gaddipati R, Gladson S, Gu E, West J, Lane KB (2012) Biol Sex Differ 3(1): 6
    › Primary publication · 22348410 (PubMed) · PMC3310853 (PubMed Central)
  49. Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance. Flynn C, Zheng S, Yan L, Hedges L, Womack B, Fessel J, Cogan J, Austin E, Loyd J, West J, Zhao Z, Hamid R (2012) Am J Respir Cell Mol Biol 47(1): 20-7
    › Primary publication · 22312021 (PubMed) · PMC3402799 (PubMed Central)
  50. Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression. Austin ED, Menon S, Hemnes AR, Robinson LR, Talati M, Fox KL, Cogan JD, Hamid R, Hedges LK, Robbins I, Lane K, Newman JH, Loyd JE, West J (2011) Pulm Circ 1(3): 389-98
    › Primary publication · 22140629 (PubMed) · PMC3224431 (PubMed Central)
  51. The genetics of pulmonary arterial hypertension in the post-BMPR2 era. Fessel JP, Loyd JE, Austin ED (2011) Pulm Circ 1(3): 305-19
    › Primary publication · 22140620 (PubMed) · PMC3224422 (PubMed Central)
  52. Programmatic change: lung disease research in the era of induced pluripotency. Ikonomou L, Hemnes AR, Bilousova G, Hamid R, Loyd JE, Hatzopoulos AK, Kotton DN, Majka SM, Austin ED (2011) Am J Physiol Lung Cell Mol Physiol 301(6): L830-5
    › Primary publication · 21984571 (PubMed) · PMC3233828 (PubMed Central)
  53. Oxidative injury is a common consequence of BMPR2 mutations. Lane KL, Talati M, Austin E, Hemnes AR, Johnson JA, Fessel JP, Blackwell T, Mernaugh RL, Robinson L, Fike C, Roberts LJ, West J (2011) Pulm Circ 1(1): 72-83
    › Primary publication · 21904662 (PubMed) · PMC3167174 (PubMed Central)
  54. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH (2011) Chest 140(5): 1267-1273
    › Primary publication · 21622547 (PubMed) · PMC4694178 (PubMed Central)
  55. Somatic mutations in pulmonary arterial hypertension: primary or secondary events? Austin ED, Hamid R, Ahmad F (2010) Am J Respir Crit Care Med 182(9): 1094-6
    › Primary publication · 21041561 (PubMed)
  56. Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension. Hamid R, Hedges LK, Austin E, Phillips JA, Loyd JE, Cogan JD (2010) Clin Genet 77(3): 280-6
    › Primary publication · 20095988 (PubMed) · PMC3741656 (PubMed Central)
  57. T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension. Austin ED, Rock MT, Mosse CA, Vnencak-Jones CL, Yoder SM, Robbins IM, Loyd JE, Meyrick BO (2010) Respir Med 104(3): 454-62
    › Primary publication · 19880300 (PubMed) · PMC2826574 (PubMed Central)
  58. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Austin ED, Phillips JA, Cogan JD, Hamid R, Yu C, Stanton KC, Phillips CA, Wheeler LA, Robbins IM, Newman JH, Loyd JE (2009) Respir Res : 87
    › Primary publication · 19785764 (PubMed) · PMC2762975 (PubMed Central)
  59. Genetics of pulmonary arterial hypertension. Austin ED, Loyd JE, Phillips JA (2009) Semin Respir Crit Care Med 30(4): 386-98
    › Primary publication · 19634078 (PubMed) · PMC3737593 (PubMed Central)
  60. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Austin ED, Cogan JD, West JD, Hedges LK, Hamid R, Dawson EP, Wheeler LA, Parl FF, Loyd JE, Phillips JA (2009) Eur Respir J 34(5): 1093-9
    › Primary publication · 19357154 (PubMed) · PMC3742124 (PubMed Central)
  61. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele. Hamid R, Cogan JD, Hedges LK, Austin E, Phillips JA, Newman JH, Loyd JE (2009) Hum Mutat 30(4): 649-54
    › Primary publication · 19206171 (PubMed) · PMC2663001 (PubMed Central)
  62. Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Phillips JA, Poling JS, Phillips CA, Stanton KC, Austin ED, Cogan JD, Wheeler L, Yu C, Newman JH, Dietz HC, Loyd JE (2008) Genet Med 10(5): 359-65
    › Primary publication · 18496036 (PubMed)
  63. Genetics and mediators in pulmonary arterial hypertension. Austin ED, Loyd JE (2007) Clin Chest Med 28(1): 43-57, vii-viii
    › Primary publication · 17338927 (PubMed) · PMC3740514 (PubMed Central)